C1QA antibody
Quick Overview for C1QA antibody (ABIN7227540)
Target
See all C1QA AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- C1QA Polyclonal Antibody
-
Specificity
- The antibody detects endogenous levels of C1QA protein
-
Purification
- The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen
-
Immunogen
- Synthesized peptide derived from part region of human C1QA protein
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB (1:500-1:2000), ELISA (1:5000-1:20000).
-
Comment
-
Primary Antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, pH 7.4, containing 0.02 % Sodium Azide as preservative and 50 % Glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
-
- C1QA (Complement Component 1, Q Subcomponent, A Chain (C1QA))
-
Alternative Name
- C1QA
-
Background
- Rabbit Anti-C1QA Polyclonal Antibody,Complement C1q subcomponent subunit A,C1QA encodes the A-chain polypeptide of serum complement subcomponent C1q, which associates with C1r and C1s to yield the first component of the serum complement system. C1q deficiency is associated with lupus erythematosus and glomerulonephritis. C1q is composed of 18 polypeptide chains which include 6 A-chains, 6 B-chains, and 6 C-chains. Each chain contains an N-terminal collagen-like region and a C-terminal C1q globular domain. Alternate splicing results in multiple transcript variants.,C1QA
-
Molecular Weight
- observerd band 26kDa
-
Gene ID
- 712
-
UniProt
- P02745
-
Pathways
- Complement System
Target
-